MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio
MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio
kdunleavy
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *